Results 161 to 170 of about 16,042 (257)

Assessment of a two-dose administration of oral poliovirus vaccine for virulent vaccine-derived polioviruses

, 2008
H. Horie, Masae Iwai, Takashi Nakayama, Kumiko Matsuura, T. Takizawa, Hiromu Yoshida   +5 more
openalex   +1 more source

Immunogenicity evaluation of primary polio vaccination schedule with inactivated poliovirus vaccines and bivalent oral poliovirus vaccine. [PDF]

BMC Infect Dis
Xu J, Liu Y, Qiu W, Li W, Hu X, Li X, Fan Q, Tang W, Wang Y, Wang Q, Yao N.   +10 more
europepmc   +1 more source

Expected Implications of Globally Coordinated Cessation of Serotype 3 Oral Poliovirus Vaccine (OPV) Before Serotype 1 OPV. [PDF]

Risk Anal, 2021
Kalkowska DA, Thompson KM.
europepmc   +1 more source

The duration of intestinal immunity after an inactivated poliovirus vaccine booster dose in children immunized with oral vaccine: a randomised controlled trial [PDF]

, 2016
Jacob John, Sidhartha Giri, Arun S Karthikeyan, Dipti Lata, Shalini Jeyapaul, Anand Rajan, Nirmal Kumar, Pavithra Dhanapal, V. Jayalakshmi, M Mohanraj, J Hanusha, Uma Raman, Prabhakar D. Moses, Asha Mary Abraham, Sunil Bahl, Ananda S Bandyopadhyay, Mohammad Ahmad, Nicholas C. Grassly, Gagandeep Kang   +18 more
openalex   +1 more source

Application of MPBT Assay for Multiplex Determination of Infectious Titers and for Selection of the Optimal Formulation for the Trivalent Novel Oral Poliovirus Vaccine. [PDF]

Viruses
Manukyan H, Lal M, Zhu C, Singh O, Lin TL, Tritama E, Chumakov K, Lee SM, Laassri M.   +8 more
europepmc   +1 more source

Updated Characterization of Outbreak Response Strategies for 2019-2029: Impacts of Using a Novel Type 2 Oral Poliovirus Vaccine Strain. [PDF]

Risk Anal, 2021
Kalkowska DA, Pallansch MA, Wilkinson A, Bandyopadhyay AS, Konopka-Anstadt JL, Burns CC, Oberste MS, Wassilak SGF, Badizadegan K, Thompson KM.   +9 more
europepmc   +1 more source

Intramuscular Injections within 30 Days of Immunization with Oral Poliovirus Vaccine — A Risk Factor for Vaccine-Associated Paralytic Poliomyelitis [PDF]

, 1995
Peter M. Strebel, N Ion-Nedelcu, Andrew L. Baughman, Roland W. Sutter, Stephen L. Cochi   +4 more
openalex   +1 more source

Sequential inactivated and oral poliovirus vaccine schedules: a balancing act. [PDF]

Lancet Infect Dis, 2020
Zaman K, Anand A.
europepmc   +1 more source

Community transmission of type 2 poliovirus after cessation of trivalent oral polio vaccine in Bangladesh: an open-label cluster-randomised trial and modelling study [PDF]

, 2017
Mami Taniuchi, Michael Famulare, Khalequ Zaman, Md. Jashim Uddin, Alexander Upfill‐Brown, Tahmina Ahmed, Parimalendu Saha, Rashidul Haque, Ananda S Bandyopadhyay, John F. Modlin, James A Platts-Mills, Eric R. Houpt, Mohammad Yunus, William A. Petri   +13 more
openalex   +1 more source

The Immunogenicity of Monovalent Oral Poliovirus Vaccine Type 1 (mOPV1) and Inactivated Poliovirus Vaccine (IPV) in the EPI Schedule of India. [PDF]

Vaccines (Basel)
Mohanty L, John TJ, Pawar SD, Ramanan PV, Agarkhedkar S, Haldar P.   +5 more
europepmc   +1 more source